anti-VZV antibody product blog
Tags: Antibody; Monoclonal Antibody; VZV; anti-VZV antibody;
The VZV n/a (Catalog #MBS531845) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The VZV (early gene 62) antibody reacts with Varicella zoster virus and may cross-react with other species as described in the data sheet. MyBioSource\'s VZV can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence (IF), Immunoprecipitation (IP), Western Blot (WB). Researchers should empirically determine the suitability of the VZV n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal VZV (early gene 62) antibody.
Biological Significance: Varicella-Zoster Virus (VZV) is the etiologic agent of two clinical diseases: Chickenpox (Varicella) and Shingles (Zoster). Chickenpox is an acute generalized disease with the sudden onset of fever and vesicular eruptions of the skin and mucous membranes. After an attack of chickenpox, the Varicella-Zoster virus lies dormant in the nerve tissue with the possibility of reactivation in the form of shingles, which may be manifest as an outbreak of a rash or blisters on the skin. The immediate-early protein IE62 is a major component of virus particles and initiates transcription from its own and other VZV gene promoters, acting synergistically with several viral and cellular transactivating proteins. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling.
Immunogen: VZV (early gene 62) antibody was raised in ouse using Varicella Zoster Virus HZ as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing VZV are readily searchable from our website. Different antibodies against the same target such as VZV may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.